Close This website uses modern features that are not supported by your browser. Click here for more information.
Please upgrade to a modern browser to view this website properly. Google Chrome Mozilla Firefox Opera Safari
your legal news hub
Sub Menu
Search

Search

Filter
Filter
Filter
A A A

WHO issues cough syrup alert

Publish date: 24 July 2023
Issue Number: 1037
Diary: IBA Legalbrief Africa
Category: Cameroon

The WHO has issued an alert regarding a batch of contaminated cough syrup sold in Cameroon, noting that it contained unacceptable amounts of contaminant chemicals. Deutsche Welle reports the stated active ingredients of Naturcold syrup are listed as paracetamol, phenylephrine hydrochloride and chlorpheniramine maleate – a combination used to relieve symptoms associated with the common cold, flu and allergic rhinitis. The medicine was analysed in a WHO-contracted laboratory after samples from Cameroon were made available last month. As much as 28.6% diethylene glycol was detected in the syrup. The acceptable limit is no more than 0.10%. Diethylene glycol is normally used as a solvent, but can be illicitly put in medicine as a cheap alternative to more expensive ingredients. The product packaging lists Fraken International (England) as a manufacturer, but the UK national regulatory authority has confirmed that no such company exists in the UK.

Full Deutsche Welle report

We use cookies to give you a personalised experience that suits your online behaviour on our websites. Otherwise, you may click here to learn more, or learn how to block or disable cookies. Disabling cookies might cause you to experience difficulties on our website as some functionality relies on cookie information. You can change your mind at any time by visiting “Cookie Preferences”. Any personal data about you will be used as described in our Privacy Policy.